37th Annual Advances in Heart Disease
J

Subcutaneous vs. Transvenous ICD: What Are the Implant Techniques and How They May Influence Device Selection and Efficacy?

By 37th Annual Advances in Heart Disease FEATURING Joshua Moss
By 37th Annual Advances in Heart Disease FEATURING Joshua Moss
181 views
February 5, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
16:31
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Cardiac Sarcoidosis: Improving Diagnosis and Management

Feat. B. Chung
02:44
Boston Scientific

LUX-Dx ICM Tachycardia Algorithm

04:48
Boston Scientific

Engineered for Advance Control

Feat. D. Perschbacher, S. Vanderline, J. Kelly, S. Saha
01:02
Boston Scientific

How the LUX-Dx ICM Morphology Assessment Works

Feat. D. Perschbacher
02:37
Boston Scientific

Positioning Can in the Pocket: S-ICD Implant Best Practices (8 of 8)

Feat. I. Almasry
04:22
CVRx | Barostim

Barostim Patient Identification

Feat. R. Canby
57
Boston Scientific

Tailor LUX-Dx ICM Program Settings Remotely

Feat. D. Perschbacher
36:07
Scripps Health

Disparities in Care: Pacer/ICD/CRT in WOMEN - a 2023 Update

Feat. J. Rogers
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
07:41
CVRx | Barostim

New Options for Heart Failure Patients with Narrow QRS

Feat. J. Singh
18:06
Ulrika Birgersdotter-Green

Antitachycardia Pacing and VT Termination: Fact or Fancy?

10:09
Boston Scientific

Effects of ICD Leads on the Tricuspid Valve and Right Ventricle: A R…

Feat. D. Leong
18:30
ACC 2023 Conference Coverage

ACC 2023: Managing ICDs and CRTs in Patients With LVADs

Feat. R. Gopinathannair
18:58
Boston Scientific

Part 3 of 3: UNTOUCHED Trial Results

Feat. M. Gold, U. Birgersdotter-Green
12:34
CVRx | Barostim

The Need for Device Therapy in HFrEF

Feat. W. Abraham
19:17
CVRx | Barostim

EP Lab Digest Panel Q&A

Feat. J. Lindenfeld, R. Canby, N. Raval, B. Knight
03:01
BD

Patient Story: The use of Absorbable Hemostats to Control Bleeding i…

08:28
10th Annual California Heart Rhythm Symposium

Debate: Should VT Ablation Be the First Line Therapy Before ICD Impl…

Feat. W. Sauer